More GSK ghostwriting examples surface

On the heels of ghostwriting allegations involving GlaxoSmithKline and a book purportedly authored by two doctors, Talking Points Memo points out additional publications--this time in medical journals--allegedly ghosted by the same writer on behalf of GSK. The company has said that its internal guidelines governing medical writers have since been tightened up. Report

Suggested Articles

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Moderna is entering an important time, its CEO says. And the company is doing so with a new finance chief from Big Biotech.

A new NEJM study found taking hydroxychloroquine after COVID-19 exposure doesn't reduce the risk of an infection. But questions remain.